Assignee
AMYLIN PHARMACEUTICALS INC
US·108 granted patents·27 pending applications·6,082 citations·filing 1989–2010
Top patents by PatentIndex Score
135 records- 0199US6924264B1Modified exendins and exendin agonistsAMYLIN PHARMACEUTICALS INC·Filed 2000·Granted Aug 2, 2005·169 cites·23 claims
- 0298US7928065B2Methods of treatment using exendin peptides or GLP-1 peptidesAMYLIN PHARMACEUTICALS INC·Filed 2008·Granted Apr 19, 2011·63 cites·45 claims
- 0398US7858740B2Exendin agonist compoundsAMYLIN PHARMACEUTICALS INC·Filed 2006·Granted Dec 28, 2010·39 cites·9 claims
- 0498US7691963B2Exendins and exendin agonists modified with polyamino acidsAMYLIN PHARMACEUTICALS INC·Filed 2008·Granted Apr 6, 2010·48 cites·20 claims
- 0598US7419952B2Use of exendins and agonists thereof to treat diabetesAMYLIN PHARMACEUTICALS INC·Filed 2006·Granted Sep 2, 2008·53 cites·20 claims
- 0698US7153825B2Methods for glucagon suppression using modified exendinsAMYLIN PHARMACEUTICALS INC·Filed 2005·Granted Dec 26, 2006·111 cites·35 claims
- 0798US6872700B1Methods for glucagon suppressionAMYLIN PHARMACEUTICALS INC·Filed 2000·Granted Mar 29, 2005·184 cites·24 claims
- 0898US6858576B1Methods for regulating gastrointestinal motilityAMYLIN PHARMACEUTICALS INC·Filed 1997·Granted Feb 22, 2005·211 cites·22 claims
- 0997US8026210B2Exendins and exendin agonist analogs to regulate gastrointestinal motilityAMYLIN PHARMACEUTICALS INC·Filed 2009·Granted Sep 27, 2011·43 cites·21 claims
- 1097US7741269B2Exendins and exendin agonists for weight reduction and obesityAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Jun 22, 2010·88 cites·44 claims
- 1197US7683030B2Methods of treating diabetes with albumin-conjugated exendin peptidesAMYLIN PHARMACEUTICALS INC·Filed 2008·Granted Mar 23, 2010·42 cites·15 claims
- 1297US7608692B2Exendins and exendin agonists modified with albuminAMYLIN PHARMACEUTICALS INC·Filed 2008·Granted Oct 27, 2009·43 cites·12 claims
- 1397US7521423B2Exendin pharmaceutical compositionsAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Apr 21, 2009·96 cites·32 claims
- 1497US7452858B2Treatment of gestational diabetesAMYLIN PHARMACEUTICALS INC·Filed 2005·Granted Nov 18, 2008·43 cites·19 claims
- 1597US7407932B2Methods for glucagon suppression using modified exendinsAMYLIN PHARMACEUTICALS INC·Filed 2006·Granted Aug 5, 2008·41 cites·7 claims
- 1697US7297761B2Pharmaceutical compositions containing exendinsAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Nov 20, 2007·114 cites·37 claims
- 1797US7157555B1Exendin agonist compoundsAMYLIN PHARMACEUTICALS INC·Filed 1998·Granted Jan 2, 2007·132 cites·4 claims
- 1897US7138375B2Use of exendins and agonists thereof for lowering plasma lipidAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Nov 21, 2006·95 cites·20 claims
- 1997US7115569B2Exendins, exendin agonists, and methods for their useAMYLIN PHARMACEUTICALS INC·Filed 2004·Granted Oct 3, 2006·114 cites·60 claims
- 2097US6989366B2Exendins, exendin agonists, and methods for their useAMYLIN PHARMACEUTICALS INC·Filed 2002·Granted Jan 24, 2006·111 cites·42 claims
- 2197US6982248B2Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissueAMYLIN PHARMACEUTICALS INC·Filed 2001·Granted Jan 3, 2006·78 cites·28 claims
- 2297US6956026B2Use of exendins for the reduction of food intakeAMYLIN PHARMACEUTICALS INC·Filed 1998·Granted Oct 18, 2005·194 cites·68 claims
- 2397US6902744B1Exendin agonist formulations and methods of administration thereofAMYLIN PHARMACEUTICALS INC·Filed 2000·Granted Jun 7, 2005·180 cites·42 claims
- 2497US6706689B2Treatment of acute coronary syndrome with GLP-1AMYLIN PHARMACEUTICALS INC·Filed 2001·Granted Mar 16, 2004·142 cites·41 claims
- 2596US7700549B2Exendin agonist analogs to treat diabetesAMYLIN PHARMACEUTICALS INC·Filed 2008·Granted Apr 20, 2010·43 cites·18 claims
- 2696US7442680B2Inotropic and diuretic effects of GLP-1 and GLP-1 agonistsAMYLIN PHARMACEUTICALS INC·Filed 2003·Granted Oct 28, 2008·66 cites·16 claims
- 2796US6894024B2Treatment of hibernating myocardium and diabetic cardiomyopathy with a GLP-1 peptideAMYLIN PHARMACEUTICALS INC·Filed 2001·Granted May 17, 2005·91 cites·9 claims
- 2896US6703359B1Inotropic and diuretic effects of exendin and GLP-1AMYLIN PHARMACEUTICALS INC·Filed 1999·Granted Mar 9, 2004·160 cites·42 claims
- 2996US6506724B1Use of exendins and agonists thereof for the treatment of gestational diabetes mellitusAMYLIN PHARMACEUTICALS INC·Filed 1999·Granted Jan 14, 2003·177 cites·13 claims
- 3096US5686411AAmylin agonist peptides and uses thereforAMYLIN PHARMACEUTICALS INC·Filed 1995·Granted Nov 11, 1997·148 cites·45 claims
- 3195US7888314B2Compositions and methods for treating peripheral vascular diseaseAMYLIN PHARMACEUTICALS INC·Filed 2005·Granted Feb 15, 2011·22 cites·8 claims
- 3295US7696161B2Exendin agonist compoundsAMYLIN PHARMACEUTICALS INC·Filed 2007·Granted Apr 13, 2010·43 cites·48 claims
- 3395US7399489B2Exendin analog formulationsAMYLIN PHARMACEUTICALS INC·Filed 2005·Granted Jul 15, 2008·40 cites·36 claims
- 3495US7223725B1Exendin agonist compoundsAMYLIN PHARMACEUTICALS INC·Filed 1998·Granted May 29, 2007·83 cites·16 claims
- 3595US7056887B2Treatment of acute coronary syndrome with GLP-1AMYLIN PHARMACEUTICALS INC·Filed 2002·Granted Jun 6, 2006·59 cites·12 claims
- 3693US7879794B2Methods for controlling binge eating disordersAMYLIN PHARMACEUTICALS INC·Filed 2006·Granted Feb 1, 2011·28 cites·20 claims
- 3793US7259136B2Compositions and methods for treating peripheral vascular diseaseAMYLIN PHARMACEUTICALS INC·Filed 2002·Granted Aug 21, 2007·40 cites·11 claims
- 3893US7105489B2Methods and compositions for treating polycystic ovary syndromeAMYLIN PHARMACEUTICALS INC·Filed 2002·Granted Sep 12, 2006·52 cites·20 claims
- 3993US6114304AMethods for regulating gastrointestinal motilityAMYLIN PHARMACEUTICALS INC·Filed 1994·Granted Sep 5, 2000·103 cites·35 claims
- 4093US6087334AAnti-diabetic peptidesAMYLIN PHARMACEUTICALS INC·Filed 1998·Granted Jul 11, 2000·118 cites·82 claims
- 4192US7960341B2Methods and compositions for treating polycystic ovary syndromeAMYLIN PHARMACEUTICALS INC·Filed 2006·Granted Jun 14, 2011·16 cites·10 claims
- 4292US7723471B2Pancreatic polypeptide family motifs, polypeptides and methods comprising the sameAMYLIN PHARMACEUTICALS INC·Filed 2005·Granted May 25, 2010·18 cites·53 claims
- 4392US7271238B2Amylin agonist peptides and uses thereforAMYLIN PHARMACEUTICALS INC·Filed 2003·Granted Sep 18, 2007·22 cites·19 claims
- 4492US7220721B1Exendin agonist peptidesAMYLIN PHARMACEUTICALS INC·Filed 1998·Granted May 22, 2007·92 cites·75 claims
- 4592US7105490B2Methods and compositions for treating polycystic ovary syndromeAMYLIN PHARMACEUTICALS INC·Filed 2003·Granted Sep 12, 2006·35 cites·71 claims
- 4691US7981861B2Method of performing angioplasty with a GLP-1 moleculeAMYLIN PHARMACEUTICALS INC·Filed 2010·Granted Jul 19, 2011·14 cites·8 claims
- 4791US7906146B2Lyophilized formulations of exendins and exendin agonist analogsAMYLIN PHARMACEUTICALS INC·Filed 2009·Granted Mar 15, 2011·14 cites·20 claims
- 4891US7118737B2Polymer-modified synthetic proteinsAMYLIN PHARMACEUTICALS INC·Filed 2001·Granted Oct 10, 2006·60 cites·62 claims
- 4991US6998387B1Human appetite control by glucagon-like peptide receptor binding compoundsAMYLIN PHARMACEUTICALS INC·Filed 1999·Granted Feb 14, 2006·160 cites·19 claims
- 5091US5266561ATreatment of type 2 diabetes mellitusAMYLIN PHARMACEUTICALS INC·Filed 1991·Granted Nov 30, 1993·71 cites·4 claims
Showing the top 50 of 135 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when AMYLIN PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →